Global Heart Failure Academy
Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from CSL Vifor.
Episodes 1-8 of 8
- CME/CE
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
0.25 creditsDavid Wheeler, MB, CHB, MD, FRCP
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Stefan D. Anker, MD, PhD
John Cleland, MD
Piotr Ponikowski, MD, PhD, FESC, FHFA
- Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
Ewa A. Jankowska, MD, PhD, FESC
- Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Stefan D. Anker, MD, PhD
Javed Butler, MD, MBA, MPH
Ewa A. Jankowska, MD, PhD, FESC
Josep Comin-Colet, MD, PhD
- Global Heart Failure Academy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
Mikhail Kosiborod, MD
- Global Heart Failure Academy
Mechanisms in Heart Failure: Why Iron Deficiency Matters
- Global Heart Failure Academy
Balancing RAASi Therapy and Potassium: Understanding How it Works